Old Web
English
Sign In
Acemap
>
authorDetail
>
Pam McClelland
Pam McClelland
University of California, San Diego
Internal medicine
Medicine
Endocrinology
Apolipoprotein B
Agonist
3
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression
2005
Molecular Pharmacology
Jai Pal Singh
Raymond F. Kauffman
William R. Bensch
Guoming Wang
Pam McClelland
James S. Bean
Chahrzad Montrose
Nathan Bryan Mantlo
Asavari Wagle
Show All
Source
Cite
Save
Citations (22)
1116-31 Induction of marked changes in serum lipids and apolipoprotein A-1 expression in human Apo A-1 transgenic mice by a novel peroxisome proliferator-activated receptor alpha agonist LY518674
2004
Journal of the American College of Cardiology
Jai Pal Singh
Raymond F. Kauffman
Guoming Wang
Pam McClelland
William R. Bensch
Chahrzad R. Montrose
Nathan Bryan Mantlo
Asavari Wagle
Show All
Source
Cite
Save
Citations (0)
917-100 8-Epi-Prostaglandin F2α(8-Isoprostane), a Novel Marker of Lipid Peroxidation, is Elevated and Inversely Correlated to Serum Antioxidant Vitamins in Smokers
1995
Journal of the American College of Cardiology
Emile R. Mohler
Pam McClelland
David R. Hathaway
Peter D. Reaven
Show All
Source
Cite
Save
Citations (0)
1